A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency
The present clinical trial was conducted to evaluate the efficacy and tolerability of a standardized saw palmetto oil containing 3% β-sitosterol in the treatment of benign prostate hyperplasia (BPH) and androg...
Source: BMC Urology - Category: Urology & Nephrology Authors: H. V. Sudeep, Jestin V. Thomas and K. Shyamprasad Tags: Research article Source Type: research
More News: Benign Prostatic Hyperplasia | Clinical Trials | Saw Palmetto | Study | Urology & Nephrology